Spirogermanium hydrochloride

N/A

Report date: 2023/04/25 14:52:30
NME

Base Information

Drug NameSpirogermanium hydrochloride
Drug Alias Name锗螺胺盐酸锗螺胺Spiro-32NSC-192965
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksKEGG